Amount of eligible people: CDEC mentioned the uncertainty in the quantity of individuals with moderately critical to significant hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some sufferers that are categorized as getting mild or moderate condition could possibly have a intense bleeding https://hemgenix48260.yomoblog.com/42708685/everything-about-hemgenix